Medicare Payments Still “Excessive” For Albuterol And Ipatropium, IG Says
The HHS Inspector General is recommending significant further cuts in reimbursement for albuterol and ipatropium bromide under Medicare Part B
You may also be interested in...
The House Energy & Commerce/Oversight Subcommittee is directing the General Accounting Office to review Medicaid reimbursement policies in preparation for debate over reforms to the program
Drug manufacturers' first quarter average sales price reports are due to the Centers for Medicare & Medicaid Services April 30
Johnson & Johnson's Procrit will be reimbursed at 87% of average wholesale price under Medicare Part B in 2004, two percentage points higher than most drugs